Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH.
Urban P, Stauffer JC, Bleed D, Khatchatrian N, Amann W, Bertel O, van den Brand M, Danchin N, Kaufmann U, Meier B, Machecourt J, Pfisterer M. Urban P, et al. Among authors: pfisterer m. Eur Heart J. 1999 Jul;20(14):1030-8. doi: 10.1053/euhj.1998.1353. Eur Heart J. 1999. PMID: 10383377 Clinical Trial.
Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trial.
Kaiser C, Kuster GM, Erne P, Amann W, Naegeli B, Osswald S, Buser P, Schläpfer H, Brett W, Zerkowski HR, Schindler C, Pfisterer M; TIME Investigators. Kaiser C, et al. Among authors: pfisterer m. Eur Heart J. 2004 Jun;25(12):1036-42. doi: 10.1016/j.ehj.2004.02.033. Eur Heart J. 2004. PMID: 15191774 Free article. Clinical Trial.
Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design.
Pfisterer M, Bertel O, Bonetti PO, Brunner-La Rocca HP, Eberli FR, Erne P, Galatius S, Hornig B, Kiowski W, Pachinger O, Pedrazzini G, Rickli H, De Servi S, Kaiser C; BASKET-PROVE Investigators. Pfisterer M, et al. Am Heart J. 2008 Apr;155(4):609-14. doi: 10.1016/j.ahj.2007.11.011. Epub 2008 Feb 21. Am Heart J. 2008. PMID: 18371466 Clinical Trial.
Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.
Pfisterer M, Buser P, Osswald S, Allemann U, Amann W, Angehrn W, Eeckhout E, Erne P, Estlinbaum W, Kuster G, Moccetti T, Naegeli B, Rickenbacher P; Trial of Invasive versus Medical therapy in Elderly patients (TIME) Investigators. Pfisterer M, et al. JAMA. 2003 Mar 5;289(9):1117-23. doi: 10.1001/jama.289.9.1117. JAMA. 2003. PMID: 12622581 Clinical Trial.
Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).
Claude J, Schindler C, Kuster GM, Schwenkglenks M, Szucs T, Buser P, Osswald S, Kaiser C, Grädel C, Estlinbaum W, Rickenbacher P, Pfisterer M; Trial of Invasive versus Medical therapy in the Elderly (TIME) Investigators. Claude J, et al. Among authors: pfisterer m. Eur Heart J. 2004 Dec;25(24):2195-203. doi: 10.1016/j.ehj.2004.09.013. Eur Heart J. 2004. PMID: 15589636 Clinical Trial.
Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.
Vassalli G, Klersy C, De Servi S, Galatius S, Erne P, Eberli F, Rickli H, Hornig B, Bertel O, Bonetti P, Moccetti T, Kaiser C, Pfisterer M, Pedrazzini G; BASKET-PROVE Investigators. Vassalli G, et al. Among authors: pfisterer m. Am Heart J. 2016 Mar;173:1-7. doi: 10.1016/j.ahj.2015.11.007. Epub 2015 Dec 1. Am Heart J. 2016. PMID: 26920590 Clinical Trial.
439 results